Combined Synopsis/SolicitationPosted Sep 2, 2026·Responses due Sep 16, 2026

FY27-28 Adult Flu Vaccines

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Open solicitation
NAICS
325412
Value
Not stated
Solicitation
75D30126R73517
Set-aside
No Set aside used
PSC
6505
Place
Atlanta, GA, USA
Contact
Cole Mullis (ttu3@cdc.gov)
…Open on SAM.gov
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D30126R73517 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 2, 2026 · this notice
    Combined Synopsis/Solicitation
  • Sep 9, 2026
    Combined Synopsis/Solicitation
    Open
Award
Not yet. Too few past cases at this agency to estimate timing (7 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

The Centers for Disease Control and Prevention (CDC) awards one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease. The 317 program as established under Section 317(j) of the Public Health Service Act, … (show all)

works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease�s (NCIRD�s) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.

Who won similar work

13 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.

WinnerAwardsValueLast
GLAXOSMITHKLINE, LLC3$1.7BMar 27, 2026
SEQIRUS USA INC2$663.9MDec 31, 2024
SANOFI PASTEUR INC.2$233.3MDec 31, 2024
ASTRAZENECA PHARMACEUTICALS LP2$61.0MDec 31, 2024
MERCK SHARP & DOHME LLC · $MRK1$4.5BMar 27, 2026
PFIZER INC · $PFE1$2.1BMar 27, 2026
SANOFI VACCINES US INC.1$1.9BMar 27, 2026
BAVARIAN NORDIC, INC.1$7.0MMar 27, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 2 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (9 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • $243K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 6 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 2 of the past winners are listed companies
  • 3 insider buys and 8 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.